These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12660549)

  • 1. Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine?
    Youle M; Wainberg MA
    AIDS; 2003 Apr; 17(6):937-8. PubMed ID: 12660549
    [No Abstract]   [Full Text] [Related]  

  • 2. An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic.
    Fauci AS
    JAMA; 2017 Oct; 318(16):1535-1536. PubMed ID: 29052689
    [No Abstract]   [Full Text] [Related]  

  • 3. Cure of HIV infection: is the long wait over?
    Shearer WT
    J Allergy Clin Immunol; 2014 Jul; 134(1):20-2. PubMed ID: 25117800
    [No Abstract]   [Full Text] [Related]  

  • 4. 25 years after HIV discovery: prospects for cure and vaccine.
    Montagnier L
    Virology; 2010 Feb; 397(2):248-54. PubMed ID: 20152474
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV neutralizing antibodies reignite interest in vaccine.
    Waltz E
    Nat Biotechnol; 2012 Mar; 30(3):204-5. PubMed ID: 22398603
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV prevention & treatment strategies - Current challenges & future prospects.
    Bhattacharya J
    Indian J Med Res; 2018 Dec; 148(6):671-674. PubMed ID: 30777998
    [No Abstract]   [Full Text] [Related]  

  • 7. Feasibility of chemoprophylaxis studies in high risk HIV-seronegative populations.
    Gross M; Holte S; Seage GR; Buchbinder SP; Metzger DS; Mayer KH
    AIDS Educ Prev; 2000 Feb; 12(1):71-8. PubMed ID: 10749387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The human immunodeficiency virus. In search of an effective prophylaxis].
    Ciufecu C
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(3-4):147-50. PubMed ID: 9116404
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV prevention picks up momentum.
    Kresge KJ
    IAVI Rep; 2006; 10(4):1, 6-8. PubMed ID: 20217932
    [No Abstract]   [Full Text] [Related]  

  • 10. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.
    Desai K; Sansom SL; Ackers ML; Stewart SR; Hall HI; Hu DJ; Sanders R; Scotton CR; Soorapanth S; Boily MC; Garnett GP; McElroy PD
    AIDS; 2008 Sep; 22(14):1829-39. PubMed ID: 18753932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selection of trends in HIV research.
    Bean P
    Am Clin Lab; 2001 Jul; 20(6):12-4. PubMed ID: 11480386
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress Toward HIV Eradication: Case Reports, Current Efforts, and the Challenges Associated with Cure.
    Martin AR; Siliciano RF
    Annu Rev Med; 2016; 67():215-28. PubMed ID: 26526767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provision of treatment in HIV-1 vaccine trials in developing countries.
    Fitzgerald DW; Pape JW; Wasserheit JN; Counts GW; Counts GW; Corey L
    Lancet; 2003 Sep; 362(9388):993-4. PubMed ID: 14513852
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethical challenges of HIV vaccine trials in less developed nations: conflict and consensus in the international arena.
    Bayer R
    AIDS; 2000 May; 14(8):1051-7. PubMed ID: 10853988
    [No Abstract]   [Full Text] [Related]  

  • 15. Thorny issues in the ethics of AIDS vaccine trials.
    Berkley S
    Lancet; 2003 Sep; 362(9388):992. PubMed ID: 14513850
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges and counter challenges in HIV/AIDS.
    Li Q; Wood C
    Chin Med J (Engl); 2010 Dec; 123(23):3379-80. PubMed ID: 22166517
    [No Abstract]   [Full Text] [Related]  

  • 17. Stemming the HIV epidemic: prevention and therapy go hand in hand.
    Stebbing J; Gazzard B
    J HIV Ther; 2003 Aug; 8(3):51-4. PubMed ID: 12951542
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV prevention 2010: where are we now and where are we going?
    Cohen MS; Fidler S
    Curr Opin HIV AIDS; 2010 Jul; 5(4):265-8. PubMed ID: 20539086
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress on prevention and cure.
    Jefferys R
    IAVI Rep; 2014; 18(1):4-11. PubMed ID: 24933924
    [No Abstract]   [Full Text] [Related]  

  • 20. Retrovirus meeting. Back-to-basics push as HIV prevention struggles.
    Cohen J
    Science; 2008 Feb; 319(5865):888. PubMed ID: 18276859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.